We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.17B
AUM Growth
-$6.39M
Cap. Flow
+$112M
Cap. Flow %
5.16%
Top 10 Hldgs %
36.67%
Holding
3,684
New
390
Increased
1,388
Reduced
1,049
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 12.44%
2 Healthcare 9.68%
3 Financials 8.68%
4 Consumer Discretionary 4.31%
5 Communication Services 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSII
2751
DELISTED
Cardiovascular Systems, Inc.
CSII
$2K ﹤0.01%
+155
New +$2.3K
SJI
2752
DELISTED
South Jersey Industries, Inc.
SJI
$2K ﹤0.01%
71
-6
-8% -$205
PFHD
2753
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$2K ﹤0.01%
+78
New +$1.99K
TCDA
2754
DELISTED
Tricida, Inc. Common Stock
TCDA
$2K ﹤0.01%
195
+177
+983% +$1.94K
FEO
2755
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$2K ﹤0.01%
203
TEN
2756
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$2K ﹤0.01%
118
CYBE
2757
DELISTED
Cyberoptics Corp
CYBE
$2K ﹤0.01%
+38
New +$1.78K
EMBK
2758
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$2K ﹤0.01%
244
-1
-0.4% -$10
ABEO icon
2759
Abeona Therapeutics
ABEO
$413M
$1K ﹤0.01%
400
ABG icon
2760
Asbury Automotive
ABG
$3.85B
$1K ﹤0.01%
+4
New +$681
ABM icon
2761
ABM Industries
ABM
$2.84B
$1K ﹤0.01%
32
-1
-3% -$44
ABR icon
2762
Arbor Realty Trust
ABR
$998M
$1K ﹤0.01%
51
+30
+143% +$441
ABUS icon
2763
Arbutus Biopharma
ABUS
$915M
$1K ﹤0.01%
550
-169
-24% -$398
ACB
2764
Aurora Cannabis
ACB
$185M
$1K ﹤0.01%
100
ACLS icon
2765
Axcelis
ACLS
$4.33B
$1K ﹤0.01%
+23
New +$1.49K
ADVM
2766
DELISTED
Adverum Biotechnologies
ADVM
$1K ﹤0.01%
100
AGL icon
2767
Agilon Health
AGL
$1.6B
$1K ﹤0.01%
+2
New +$1.2K
AIN icon
2768
Albany International
AIN
$1.78B
$1K ﹤0.01%
8
-13
-62% -$1.12K
ALIT icon
2769
Alight
ALIT
$407M
$1K ﹤0.01%
4
-1
-20% -$154
ALLO icon
2770
Allogene Therapeutics
ALLO
$694M
$1K ﹤0.01%
124
-464
-79% -$6.3K
ALT icon
2771
Altimmune
ALT
$599M
$1K ﹤0.01%
40
-400
-91% -$5.91K
OSG
2772
Octave Specialty Group
OSG
$222M
$1K ﹤0.01%
115
+31
+37% +$413
AMBP icon
2773
Ardagh Metal Packaging
AMBP
$3.01B
$1K ﹤0.01%
226
+172
+319% +$1.05K
AMR icon
2774
Alpha Metallurgical Resources
AMR
$1.93B
$1K ﹤0.01%
6
+3
+100% +$417
AMRC icon
2775
Ameresco
AMRC
$1.36B
$1K ﹤0.01%
21

Similar funds

Parallel Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Parallel Advisors held 3,684 positions worth $2.17B, down 0.29% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $112M of net new capital in Q3 2022, opening 390 new positions and adding to 1,388 existing holdings. Its largest new stake was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $24.4M trimmed.

  • Parallel Advisors's largest Q3 2022 buy was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
  • Parallel Advisors added most to iShares International Select Dividend ETF in Q3 2022, an estimated $42.9M increase.
  • Parallel Advisors's biggest Q3 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $24.4M.
  • Parallel Advisors fully exited Sanderson Farms Inc in Q3 2022, selling an estimated $503K.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.17B portfolio in Q3 2022.
  • Parallel Advisors opened 390 new positions and closed 222 in Q3 2022.
  • Parallel Advisors's portfolio value fell 0.29% quarter-over-quarter to $2.17B.

Based on Parallel Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.